Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 4 clinical trials
Effects of Triiodothyronine (T3) in Ischemic Heart Failure

This study aims to determine whether giving triiodothyronine (T3), a thyroid hormone, is safe and helps improve symptoms and signs of heart failure. The study is divided into 2 phases. In the first phase, participants have a 50-50 chance of receiving the study drug. Participants who are randomized to receive …

beta blockers
heart failure
cardiac resynchronization therapy
ejection fraction
  • 12 Jul, 2022
  • 2 locations
Sacubitril/Valsartan Versus Valsartan in Heart Failure With Improved Ejection Fraction

Heart failure (HF) is a chronic disease with weakened heart muscles or abnormal pressure within the heart chambers result in breathlessness, leg edema, or fatigue. A subclass of HF shows reduced heart muscle contractility, which is represented by the left ventricular ejection fraction (LVEF). Valsartan is an angiotensin II receptor …

  • 28 Aug, 2021
  • 1 location
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification. (STOPRISK)

Study is conducted to assess the prevalence and structure of comorbidity among patients undergoing abdominal surgery and produce the stratification of the risk of postoperative complications by identifying independent predictors for its development.

  • 13 May, 2022
  • 32 locations
CCM Italian Registry

The Cardiac Contractility Modulation (CCM) system is a cardiac implantable device indicated for the treatment of patients with symptomatic heart failure with left ventricular systolic dysfunction despite optimal medical and electrical therapy. This system consists of a generator to which two stimulation leads are connected, which are fixed on the …

cardiac resynchronization therapy
ace inhibitor
heart transplantation
  • 03 Mar, 2022
  • 1 location